PBPennan M. Barry

Pennan M. Barry

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pennan M. Barry has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Charlotte K. Kent

    4 shared publications
  • Jeffrey D. Klausner

    4 shared publications
  • Ameera Snell

    2 shared publications
  • Jeffrey D Klausner

    San Francisco Department of Public Health, San Francisco, California, USA; University of California–San Francisco, San Francisco, California, USA 1360 Mission Street, Suite 401, San Francisco, CA 94103, USA +1 415 355 2000; +1 415 554 9636

    2 shared publications
  • Joseph Goldenson

    From the *Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia; and †STD Prevention and Control Services, ‡Jail Health Services, San Francisco Department of Public Health, San Francisco, California

    2 shared publications
  • Katherine C. Scott

    From the *Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia; and †STD Prevention and Control Services, ‡Jail Health Services, San Francisco Department of Public Health, San Francisco, California

    2 shared publications

Latest Publications

  • Results of a Program to Test Women for Rectal Chlamydia and Gonorrhea

    by Pennan M. Barry, Charlotte K. Kent, Susan S. Philip, Jeffrey D. Klausner

    To analyze whether rectal testing among women increased chlamydia and gonorrhea case-finding and whether reported receptive anal intercourse was a risk factor for rectal infection. From March 2007 to August 2008, women receiving pelvic examinations at the San Francisco sexually transmitted disease clinic were tested for rectal gonorrhea and chlamydia by using a transcription-mediated amplification assay. Results of testing and clinical and demographic data were analyzed using a cross-sectional study design. Of 1,308 women with both rectal and vaginal tests, test results were positive for 79 patients (6.0%) for rectal chlamydia or gonorrhea and 88 patients (6.7%) for genital chlamydia or gonorrhea. Test results were positive for 13 patients (1.0%) at the rectum only, increasing detection from 88 to 101 patients (14.8%; 95% confidence interval 8.1-23.9). No correlation existed between reported anal sex and rectal chlamydia (P=.74); however, 50% of women with rectal gonorrhea reported anal sex compared with 21% of women without rectal gonorrhea (P=.002). Sexually transmitted disease clinics might improve chlamydia and gonorrhea case-finding through rectal testing of women, but more study is needed to determine the effects of finding and treating such infections. Reporting anal intercourse did not predict rectal chlamydial infection among women tested at both the rectum and the vagina. II.


  • The use of cephalosporins for gonorrhea: the impending problem of resistance

    by Pennan M Barry, Jeffrey D Klausner

    (2009). The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opinion on Pharmacotherapy: Vol. 10, No. 4, pp. 555-577.


  • Is Jail Screening Associated With a Decrease in Chlamydia Positivity Among Females Seeking Health Services at Community Clinics?—San Francisco, 1997–2004

    by Pennan M. Barry, Charlotte K. Kent, Katherine C. Scott, Joseph Goldenson, Jeffrey D. Klausner

    Background: Young adults entering jail are at increased risk for sexually transmitted diseases (STD) such as chlamydia, are released quickly, and are unlikely to be tested for STDs elsewhere. San Francisco jails performed targeted chlamydia screening and treatment since 1996. Goal: To determine this program’s impact on chlamydia positivity among females attending neighborhood medical clinics. Study Design: During 1997–2004, jail testing density, a measure of the proportion of persons from year 2000 census blocks that were tested in jail, was compared by neighborhood. Chlamydia positivity among females aged 15 to 25 years were compared at 2 clinics serving areas with different jail testing densities. Results: Of persons offered screening at intake, 89% accepted. A total of 42,952 tests were performed among 23,561 persons in jail (45% black, 73% male). A total of 2765 (6.4%) tests were positive for chlamydia; 81% of chlamydial infections were treated. Jail testing density significantly correlated with neighborhood female chlamydia rates. Mean jail testing density at Clinic S, calculated by using the residence of persons tested for chlamydia, was 7 times greater than that at Clinic O. Chlamydia positivity declined at Clinic S from 16.1% to 7.8% (Ptrend Ptrend = 0.81). Conclusions: In San Francisco, screening young adults in jail focused testing on persons from neighborhoods with high chlamydia rates. Jail screening started immediately before chlamydia declines among young females at a clinic serving neighborhoods with high jail testing density. These programs might help reduce community prevalence and racial/ethnic disparities in STDs.


  • Risk Factors for Gonorrhea Among Heterosexuals—San Francisco, 2006

    by Pennan M. Barry, Charlotte K. Kent, Jeffrey D. Klausner

    Goal: In San Francisco, coinciding with increases in the western United States, we observed substantial gonorrhea increases among young heterosexuals during 2003-2005. We conducted a case-control study to identify intervention strategies for prevention and control. Study Design: We interviewed case patients with gonorrhea during February-July, 2006 and control subjects at the local Department of Motor Vehicles. We included sexually active heterosexuals aged 15 to 35 years in sex-stratified analyses. Results: We interviewed 225 persons: 24 male and 28 female case patients and 98 male and 75 female control subjects. In multivariable analysis adjusting for black race and multiple partners among men, black race (adjusted odds ratio (AOR), 5.1; 95% confidence interval (CI), 1.7-15.0), having had multiple partners (AOR, 3.1; 95% CI, 1.1- 8.5), having had an anonymous partner (AOR, 6.4; 95% CI, 1.9 -21.4), and a long-term partnership (AOR, 0.3; 95% CI, 0.1- 0.9) were associated with gonococcal infection. Among women, after ad- justment for age, multiple partners, and black race (subject or part- ner), being black or having a black partner (AOR, 6.9; 95% CI, 2.2-21.8), having had a recently incarcerated partner (AOR, 6.2; 95% CI, 1.0 -38.4), or meeting partners on the street (AOR, 19.0; 95% CI, 2.0 -179.0) were associated with gonococcal infection. Conclusions: Demographic and behavioral factors increase risk for gonorrhea among heterosexuals in San Francisco with partner char- acteristics being particularly important. Prevention and control efforts are focusing on blacks and incarcerated populations using street-based outreach and expanded screening and treatment. GONORRHEA CONTINUES TO BE a critical public health prob- lem: it is the second most common reportable disease in the United States. The number of gonorrhea cases reported in the United States had been declining, but in 2005, increased gonorrhea rates were observed in multiple western states, including California.1,2


  • Stay in School? Results of a Sexually Transmitted Diseases Screening Program in San Francisco High Schools—2007

    by Pennan M. Barry, Katherine C. Scott, Jacqueline McCright, Ameera Snell, Monica Lee, Trish Bascom, Charlotte K. Kent, Jeffrey D. Klausner

    To provide chlamydia and gonorrhea screening and treatment to adolescents presumed to be at high risk, school screening was conducted among the 11th and 12th graders in San Francisco. Two schools in neighborhoods with high chlamydia and gonorrhea rates and student populations > or = 15% black were chosen. Students viewed a 10-minute presentation and received test kits. Students decided in a private bathroom stall whether to test. All students were encouraged to return a test kit (whether they returned a urine specimen). Of 967 eligible students, 853 (88%) were in attendance. Of these, 21 (2%) declined to participate and 537 (63%) returned a specimen for testing. Students who tested were predominately heterosexual (93%) and nonwhite (99%). No students tested positive for gonorrhea; 7 (1.3%) tested positive for chlamydia. Positivity was 2.2% (5 of 227) for female students and 0.6% (2 of 310) for male students. Positivity by race/ethnicity was 5.4% (4 of 74) for blacks, 2.0% (2 of 98) for Hispanics, 0.3% (1 of 342) for Asian/Pacific Islanders, and 0% (0 of 4) for whites. The highest positivity was among black female students: 9.3% (4 of 43). Not including planning and follow-up, each case identified used 63 staff hours. Despite high participation among students attending school in high morbidity neighborhoods, few infections were identified. This is likely because students have low rates of sexual activity and do not necessarily attend neighborhood schools. Screening used substantial resources. Sexually transmitted disease control programs considering school screening should consider local epidemiology and whether schools have substantial proportions of students likely at high risk for sexually transmitted diseases.


  • Open Access

    Optimising sexually transmitted infection screening in correctional facilities: San Francisco, 2003 5

    by Pennan M Barry, Charlotte K Kent, Katherine C Scott, Ameera Snell, Joseph Goldenson, Jeffrey D Klausner

    Objectives: Sexually transmitted infection (STI) screening in correctional facilities provides access to people at high risk for STIs who might not be screened elsewhere. These screening programmes are becoming more widespread, but with decreasing funding for STI control, maximising screening impact has become increasingly important. We aimed to make recommendations about the impact of age and sex targeted screening in correctional facilities. Methods: We compared the prevalence of chlamydia and gonorrhoea for January 2003–July 2005 among different age groups of females and males screened in San Francisco correctional facilities—youth detention (12–17 years) and adult jail (18–35 years). Results: 16 975 chlamydia tests and 13 443 gonorrhoea tests were performed. The age specific chlamydia test positivity among females aged 12–17 years, 18–25 years, and 26–30 years, respectively, was 9.6% (105/1092), 9.4% (196/2088), and 6.3% (40/639), compared with 3.3% (100/3065), 6.2% (400/6470), and 3.9% (118/3046) among males. The age specific gonorrhoea test positivity among females in these same age groups was 3.2% (34/1062), 2.7% (57/2082), and 2.4% (15/635), compared with 0.7% (7/1026), 1.2% (67/5507), and 1.0% (25/2555) among males. Of the 1198 STIs identified, 1020 (85.1%) were treated. Conclusions: On the basis of this report and national data, STI control programmes with limited funds should prioritise screening females in youth detention first, women aged ⩽30 years in adult jail second, and men aged ⩽25 years in adult jail third. Males in youth detention should have a lower priority than young adults in jails.


    • 1 October 2006
      • Vol. 38  (10) , 22, 24-5

    The impact of STIs.

    by Pennan M Barry, Jeffrey D Klausner

  • Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990–2003

    by Pennan M Barry, Nicola Zetola, Jeanne C Keruly, Richard D Moore, Kelly A Gebo, Gregory M Lucas

    Objective: To investigate the association between the introduction of HAART and invasive pneumococcal disease (IPD) in HIV-infected patients. Methods: Incidence of IPD was determined from 1990 to 2003 in a cohort of HIV-infected individuals and a nested case–control study assessed risk factors of IPD. Results: There were 72 cases over 19 020 person-years of follow-up (overall IPD rate, 379/100 000 person-years). In the calendar periods 1990–1995, 1995–1998, and 1998–2003, the IPD incidence per 100 000 person-years was 279 [95% confidence interval (CI), 150–519], 377 (95% CI, 227–625) and 410 (95% CI, 308–545), respectively (P = 0.516). CD4 cell count < 200 cells/μl [odds ratio (OR), 3.0; 95% CI, 1.2–7.6), HIV RNA > 50 000 copies/ml (OR, 2.8; 95% CI, 1.2–6.5), hepatitis C (OR, 4.9; 95% CI, 1.7–14.9), serum albumin (OR, 0.1; 95% CI, 0.04–0.5), injection drug use in women (OR, 3.8; 95% CI, 1.6–8.8), and education beyond high school (OR, 0.2; 95% CI, 0.05–0.8) were significantly associated with IPD in multivariate analysis. No treatment factor, including HAART (OR, 0.7; 95% CI, 0.3–1.5) and pneumococcal vaccination (OR, 0.9; 95% CI, 0.5–1.6), was associated with IPD. Conclusions: IPD incidence did not change significantly during the widespread dissemination of HAART in this cohort. IPD risk was associated with several sociodemographic and clinical factors.